Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Neprilysin Market Growth 2022-2028

  • LP 4922701
  • 77 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Neprilysin will have significant change from previous year. According to our (LP Information) latest study, the global Neprilysin market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Neprilysin market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Neprilysin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Neprilysin market, reaching US$ million by the year 2028. As for the Europe Neprilysin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Neprilysin players cover Bioprojet SCR, Novartis AG, Pharmaleads SA, and Theravance Biopharma Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Neprilysin market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

TD-0714

STR-324

PL-265

LHW-090

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Acute Heart Failure

Cancer Pain

Hypertension

Alzheimer's Disease

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Bioprojet SCR

Novartis AG

Pharmaleads SA

Theravance Biopharma Inc

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Neprilysin Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Neprilysin by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Neprilysin by Country/Region, 2017, 2022 & 2028

2.2 Neprilysin Segment by Type

2.2.1 TD-0714

2.2.2 STR-324

2.2.3 PL-265

2.2.4 LHW-090

2.2.5 Others

2.3 Neprilysin Sales by Type

2.3.1 Global Neprilysin Sales Market Share by Type (2017-2022)

2.3.2 Global Neprilysin Revenue and Market Share by Type (2017-2022)

2.3.3 Global Neprilysin Sale Price by Type (2017-2022)

2.4 Neprilysin Segment by Application

2.4.1 Acute Heart Failure

2.4.2 Cancer Pain

2.4.3 Hypertension

2.4.4 Alzheimer's Disease

2.4.5 Others

2.5 Neprilysin Sales by Application

2.5.1 Global Neprilysin Sale Market Share by Application (2017-2022)

2.5.2 Global Neprilysin Revenue and Market Share by Application (2017-2022)

2.5.3 Global Neprilysin Sale Price by Application (2017-2022)

3 Global Neprilysin by Company

3.1 Global Neprilysin Breakdown Data by Company

3.1.1 Global Neprilysin Annual Sales by Company (2020-2022)

3.1.2 Global Neprilysin Sales Market Share by Company (2020-2022)

3.2 Global Neprilysin Annual Revenue by Company (2020-2022)

3.2.1 Global Neprilysin Revenue by Company (2020-2022)

3.2.2 Global Neprilysin Revenue Market Share by Company (2020-2022)

3.3 Global Neprilysin Sale Price by Company

3.4 Key Manufacturers Neprilysin Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Neprilysin Product Location Distribution

3.4.2 Players Neprilysin Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Neprilysin by Geographic Region

4.1 World Historic Neprilysin Market Size by Geographic Region (2017-2022)

4.1.1 Global Neprilysin Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Neprilysin Annual Revenue by Geographic Region

4.2 World Historic Neprilysin Market Size by Country/Region (2017-2022)

4.2.1 Global Neprilysin Annual Sales by Country/Region (2017-2022)

4.2.2 Global Neprilysin Annual Revenue by Country/Region

4.3 Americas Neprilysin Sales Growth

4.4 APAC Neprilysin Sales Growth

4.5 Europe Neprilysin Sales Growth

4.6 Middle East & Africa Neprilysin Sales Growth

5 Americas

5.1 Americas Neprilysin Sales by Country

5.1.1 Americas Neprilysin Sales by Country (2017-2022)

5.1.2 Americas Neprilysin Revenue by Country (2017-2022)

5.2 Americas Neprilysin Sales by Type

5.3 Americas Neprilysin Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Neprilysin Sales by Region

6.1.1 APAC Neprilysin Sales by Region (2017-2022)

6.1.2 APAC Neprilysin Revenue by Region (2017-2022)

6.2 APAC Neprilysin Sales by Type

6.3 APAC Neprilysin Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Neprilysin by Country

7.1.1 Europe Neprilysin Sales by Country (2017-2022)

7.1.2 Europe Neprilysin Revenue by Country (2017-2022)

7.2 Europe Neprilysin Sales by Type

7.3 Europe Neprilysin Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Neprilysin by Country

8.1.1 Middle East & Africa Neprilysin Sales by Country (2017-2022)

8.1.2 Middle East & Africa Neprilysin Revenue by Country (2017-2022)

8.2 Middle East & Africa Neprilysin Sales by Type

8.3 Middle East & Africa Neprilysin Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Neprilysin

10.3 Manufacturing Process Analysis of Neprilysin

10.4 Industry Chain Structure of Neprilysin

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Neprilysin Distributors

11.3 Neprilysin Customer

12 World Forecast Review for Neprilysin by Geographic Region

12.1 Global Neprilysin Market Size Forecast by Region

12.1.1 Global Neprilysin Forecast by Region (2023-2028)

12.1.2 Global Neprilysin Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Neprilysin Forecast by Type

12.7 Global Neprilysin Forecast by Application

13 Key Players Analysis

13.1 Bioprojet SCR

13.1.1 Bioprojet SCR Company Information

13.1.2 Bioprojet SCR Neprilysin Product Offered

13.1.3 Bioprojet SCR Neprilysin Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bioprojet SCR Main Business Overview

13.1.5 Bioprojet SCR Latest Developments

13.2 Novartis AG

13.2.1 Novartis AG Company Information

13.2.2 Novartis AG Neprilysin Product Offered

13.2.3 Novartis AG Neprilysin Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Novartis AG Main Business Overview

13.2.5 Novartis AG Latest Developments

13.3 Pharmaleads SA

13.3.1 Pharmaleads SA Company Information

13.3.2 Pharmaleads SA Neprilysin Product Offered

13.3.3 Pharmaleads SA Neprilysin Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Pharmaleads SA Main Business Overview

13.3.5 Pharmaleads SA Latest Developments

13.4 Theravance Biopharma Inc

13.4.1 Theravance Biopharma Inc Company Information

13.4.2 Theravance Biopharma Inc Neprilysin Product Offered

13.4.3 Theravance Biopharma Inc Neprilysin Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Theravance Biopharma Inc Main Business Overview

13.4.5 Theravance Biopharma Inc Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Neprilysin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Neprilysin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of TD-0714

Table 4. Major Players of STR-324

Table 5. Major Players of PL-265

Table 6. Major Players of LHW-090

Table 7. Major Players of Others

Table 8. Global Neprilysin Sales by Type (2017-2022) & (K Pcs)

Table 9. Global Neprilysin Sales Market Share by Type (2017-2022)

Table 10. Global Neprilysin Revenue by Type (2017-2022) & ($ million)

Table 11. Global Neprilysin Revenue Market Share by Type (2017-2022)

Table 12. Global Neprilysin Sale Price by Type (2017-2022) & (USD/Pcs)

Table 13. Global Neprilysin Sales by Application (2017-2022) & (K Pcs)

Table 14. Global Neprilysin Sales Market Share by Application (2017-2022)

Table 15. Global Neprilysin Revenue by Application (2017-2022)

Table 16. Global Neprilysin Revenue Market Share by Application (2017-2022)

Table 17. Global Neprilysin Sale Price by Application (2017-2022) & (USD/Pcs)

Table 18. Global Neprilysin Sales by Company (2020-2022) & (K Pcs)

Table 19. Global Neprilysin Sales Market Share by Company (2020-2022)

Table 20. Global Neprilysin Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Neprilysin Revenue Market Share by Company (2020-2022)

Table 22. Global Neprilysin Sale Price by Company (2020-2022) & (USD/Pcs)

Table 23. Key Manufacturers Neprilysin Producing Area Distribution and Sales Area

Table 24. Players Neprilysin Products Offered

Table 25. Neprilysin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Neprilysin Sales by Geographic Region (2017-2022) & (K Pcs)

Table 29. Global Neprilysin Sales Market Share Geographic Region (2017-2022)

Table 30. Global Neprilysin Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Neprilysin Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Neprilysin Sales by Country/Region (2017-2022) & (K Pcs)

Table 33. Global Neprilysin Sales Market Share by Country/Region (2017-2022)

Table 34. Global Neprilysin Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Neprilysin Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Neprilysin Sales by Country (2017-2022) & (K Pcs)

Table 37. Americas Neprilysin Sales Market Share by Country (2017-2022)

Table 38. Americas Neprilysin Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Neprilysin Revenue Market Share by Country (2017-2022)

Table 40. Americas Neprilysin Sales by Type (2017-2022) & (K Pcs)

Table 41. Americas Neprilysin Sales Market Share by Type (2017-2022)

Table 42. Americas Neprilysin Sales by Application (2017-2022) & (K Pcs)

Table 43. Americas Neprilysin Sales Market Share by Application (2017-2022)

Table 44. APAC Neprilysin Sales by Region (2017-2022) & (K Pcs)

Table 45. APAC Neprilysin Sales Market Share by Region (2017-2022)

Table 46. APAC Neprilysin Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Neprilysin Revenue Market Share by Region (2017-2022)

Table 48. APAC Neprilysin Sales by Type (2017-2022) & (K Pcs)

Table 49. APAC Neprilysin Sales Market Share by Type (2017-2022)

Table 50. APAC Neprilysin Sales by Application (2017-2022) & (K Pcs)

Table 51. APAC Neprilysin Sales Market Share by Application (2017-2022)

Table 52. Europe Neprilysin Sales by Country (2017-2022) & (K Pcs)

Table 53. Europe Neprilysin Sales Market Share by Country (2017-2022)

Table 54. Europe Neprilysin Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Neprilysin Revenue Market Share by Country (2017-2022)

Table 56. Europe Neprilysin Sales by Type (2017-2022) & (K Pcs)

Table 57. Europe Neprilysin Sales Market Share by Type (2017-2022)

Table 58. Europe Neprilysin Sales by Application (2017-2022) & (K Pcs)

Table 59. Europe Neprilysin Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Neprilysin Sales by Country (2017-2022) & (K Pcs)

Table 61. Middle East & Africa Neprilysin Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Neprilysin Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Neprilysin Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Neprilysin Sales by Type (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Neprilysin Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Neprilysin Sales by Application (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Neprilysin Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Neprilysin

Table 69. Key Market Challenges & Risks of Neprilysin

Table 70. Key Industry Trends of Neprilysin

Table 71. Neprilysin Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Neprilysin Distributors List

Table 74. Neprilysin Customer List

Table 75. Global Neprilysin Sales Forecast by Region (2023-2028) & (K Pcs)

Table 76. Global Neprilysin Sales Market Forecast by Region

Table 77. Global Neprilysin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Neprilysin Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Neprilysin Sales Forecast by Country (2023-2028) & (K Pcs)

Table 80. Americas Neprilysin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Neprilysin Sales Forecast by Region (2023-2028) & (K Pcs)

Table 82. APAC Neprilysin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Neprilysin Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Europe Neprilysin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Neprilysin Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Middle East & Africa Neprilysin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Neprilysin Sales Forecast by Type (2023-2028) & (K Pcs)

Table 88. Global Neprilysin Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Neprilysin Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Neprilysin Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Neprilysin Sales Forecast by Application (2023-2028) & (K Pcs)

Table 92. Global Neprilysin Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Neprilysin Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Neprilysin Revenue Market Share Forecast by Application (2023-2028)

Table 95. Bioprojet SCR Basic Information, Neprilysin Manufacturing Base, Sales Area and Its Competitors

Table 96. Bioprojet SCR Neprilysin Product Offered

Table 97. Bioprojet SCR Neprilysin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 98. Bioprojet SCR Main Business

Table 99. Bioprojet SCR Latest Developments

Table 100. Novartis AG Basic Information, Neprilysin Manufacturing Base, Sales Area and Its Competitors

Table 101. Novartis AG Neprilysin Product Offered

Table 102. Novartis AG Neprilysin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 103. Novartis AG Main Business

Table 104. Novartis AG Latest Developments

Table 105. Pharmaleads SA Basic Information, Neprilysin Manufacturing Base, Sales Area and Its Competitors

Table 106. Pharmaleads SA Neprilysin Product Offered

Table 107. Pharmaleads SA Neprilysin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 108. Pharmaleads SA Main Business

Table 109. Pharmaleads SA Latest Developments

Table 110. Theravance Biopharma Inc Basic Information, Neprilysin Manufacturing Base, Sales Area and Its Competitors

Table 111. Theravance Biopharma Inc Neprilysin Product Offered

Table 112. Theravance Biopharma Inc Neprilysin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 113. Theravance Biopharma Inc Main Business

Table 114. Theravance Biopharma Inc Latest Developments

List of Figures

Figure 1. Picture of Neprilysin

Figure 2. Neprilysin Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Neprilysin Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Neprilysin Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Neprilysin Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of TD-0714

Figure 10. Product Picture of STR-324

Figure 11. Product Picture of PL-265

Figure 12. Product Picture of LHW-090

Figure 13. Product Picture of Others

Figure 14. Global Neprilysin Sales Market Share by Type in 2021

Figure 15. Global Neprilysin Revenue Market Share by Type (2017-2022)

Figure 16. Neprilysin Consumed in Acute Heart Failure

Figure 17. Global Neprilysin Market: Acute Heart Failure (2017-2022) & (K Pcs)

Figure 18. Neprilysin Consumed in Cancer Pain

Figure 19. Global Neprilysin Market: Cancer Pain (2017-2022) & (K Pcs)

Figure 20. Neprilysin Consumed in Hypertension

Figure 21. Global Neprilysin Market: Hypertension (2017-2022) & (K Pcs)

Figure 22. Neprilysin Consumed in Alzheimer's Disease

Figure 23. Global Neprilysin Market: Alzheimer's Disease (2017-2022) & (K Pcs)

Figure 24. Neprilysin Consumed in Others

Figure 25. Global Neprilysin Market: Others (2017-2022) & (K Pcs)

Figure 26. Global Neprilysin Sales Market Share by Application (2017-2022)

Figure 27. Global Neprilysin Revenue Market Share by Application in 2021

Figure 28. Neprilysin Revenue Market by Company in 2021 ($ Million)

Figure 29. Global Neprilysin Revenue Market Share by Company in 2021

Figure 30. Global Neprilysin Sales Market Share by Geographic Region (2017-2022)

Figure 31. Global Neprilysin Revenue Market Share by Geographic Region in 2021

Figure 32. Global Neprilysin Sales Market Share by Region (2017-2022)

Figure 33. Global Neprilysin Revenue Market Share by Country/Region in 2021

Figure 34. Americas Neprilysin Sales 2017-2022 (K Pcs)

Figure 35. Americas Neprilysin Revenue 2017-2022 ($ Millions)

Figure 36. APAC Neprilysin Sales 2017-2022 (K Pcs)

Figure 37. APAC Neprilysin Revenue 2017-2022 ($ Millions)

Figure 38. Europe Neprilysin Sales 2017-2022 (K Pcs)

Figure 39. Europe Neprilysin Revenue 2017-2022 ($ Millions)

Figure 40. Middle East & Africa Neprilysin Sales 2017-2022 (K Pcs)

Figure 41. Middle East & Africa Neprilysin Revenue 2017-2022 ($ Millions)

Figure 42. Americas Neprilysin Sales Market Share by Country in 2021

Figure 43. Americas Neprilysin Revenue Market Share by Country in 2021

Figure 44. United States Neprilysin Revenue Growth 2017-2022 ($ Millions)

Figure 45. Canada Neprilysin Revenue Growth 2017-2022 ($ Millions)

Figure 46. Mexico Neprilysin Revenue Growth 2017-2022 ($ Millions)

Figure 47. Brazil Neprilysin Revenue Growth 2017-2022 ($ Millions)

Figure 48. APAC Neprilysin Sales Market Share by Region in 2021

Figure 49. APAC Neprilysin Revenue Market Share by Regions in 2021

Figure 50. China Neprilysin Revenue Growth 2017-2022 ($ Millions)

Figure 51. Japan Neprilysin Revenue Growth 2017-2022 ($ Millions)

Figure 52. South Korea Neprilysin Revenue Growth 2017-2022 ($ Millions)

Figure 53. Southeast Asia Neprilysin Revenue Growth 2017-2022 ($ Millions)

Figure 54. India Neprilysin Revenue Growth 2017-2022 ($ Millions)

Figure 55. Australia Neprilysin Revenue Growth 2017-2022 ($ Millions)

Figure 56. Europe Neprilysin Sales Market Share by Country in 2021

Figure 57. Europe Neprilysin Revenue Market Share by Country in 2021

Figure 58. Germany Neprilysin Revenue Growth 2017-2022 ($ Millions)

Figure 59. France Neprilysin Revenue Growth 2017-2022 ($ Millions)

Figure 60. UK Neprilysin Revenue Growth 2017-2022 ($ Millions)

Figure 61. Italy Neprilysin Revenue Growth 2017-2022 ($ Millions)

Figure 62. Russia Neprilysin Revenue Growth 2017-2022 ($ Millions)

Figure 63. Middle East & Africa Neprilysin Sales Market Share by Country in 2021

Figure 64. Middle East & Africa Neprilysin Revenue Market Share by Country in 2021

Figure 65. Egypt Neprilysin Revenue Growth 2017-2022 ($ Millions)

Figure 66. South Africa Neprilysin Revenue Growth 2017-2022 ($ Millions)

Figure 67. Israel Neprilysin Revenue Growth 2017-2022 ($ Millions)

Figure 68. Turkey Neprilysin Revenue Growth 2017-2022 ($ Millions)

Figure 69. GCC Country Neprilysin Revenue Growth 2017-2022 ($ Millions)

Figure 70. Manufacturing Cost Structure Analysis of Neprilysin in 2021

Figure 71. Manufacturing Process Analysis of Neprilysin

Figure 72. Industry Chain Structure of Neprilysin

Figure 73. Channels of Distribution

Figure 74. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390